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Analysis of Social Science Research Into 
Cancer Care in Low- and Middle-Income 
Countries: Improving Global Cancer 
Control Through Greater Interdisciplinary 
Research
INTRODUCTION
The scale of the global cancer burden and the 
unique social, political, and economic challenges 
that this poses have given rise to the demand for 
a new approach to policy that embraces social 
science. By drawing on research in India, Iraq, 
Kenya, Lebanon, Rwanda, and Uganda, we 
analyze how social science has contributed to 
the practical understanding of trajectories and 
solutions to global cancer control (Table 1). Only 
recently have social scientists begun to turn their 
attention to the cancer burden in low- and mid-
dle-income countries. In this analysis, we focus 
specifically on the contributions of anthropolo-
gists, sociologists, and historians to the social 
science literature while recognizing that other 
social science disciplines, such as economics, 
psychology, geography, and political science, 
have also made important contributions to the 
study of cancer. This brief review is based on our 
knowledge of the social science literature on can-
cer around the world. We do not consider ours to 
be a comprehensive literature review, although 
such an endeavor would be worthwhile. What 
follows is a critical review that highlights some of 
the most significant publications.
Anthropologists, sociologists, and historians who 
study cancer in low- and middle-income coun-
tries draw from research with patients, family 
members, physicians, and nurses and observa-
tion of hospital settings. They examine the his-
tory and politics of policy making and changes in 
social attitudes over time and provide compara-
tive accounts across societies that reveal com-
mon experiences. We have broken these studies 
into two categories: care-seeking strategies and 
interpretations of illness and practices among 
oncologists and nurses.
CARE-SEEKING STRATEGIES AND 
INTERPRETATIONS OF ILLNESS
These social science studies attempt to draw 
connections between patient understanding of 
cancer and care-seeking strategies. Anthro-
pologists, sociologists, and historians ask: How 
do patients interpret the causes of cancer and 
make sense of their illness, and what leads to 
changes in attitudes? How do interpretations of 
This analysis lays a framework for greater collaboration between the cancer community and social 
scientists in both research and policy. We argue that the growing cancer burden that low- and 
middle-income countries face is raising social, political, and economic challenges of global can-
cer that require interdisciplinary research beyond the traditional biomedical-clinical nexus. First, 
we briefly review some of the most important existing social science studies that have addressed 
cancer in low- and middle-income countries, including the main methods, approaches, and find-
ings of this research. Second, we give an overview of recent interdisciplinary collaborations be-
tween social scientists and oncologists and demonstrate how qualitative research can help us to 
understand the distinct challenges of cancer care in low- and middle-income settings. Finally, we 
identify key areas for future collaboration and suggest possible paths forward for cancer research 
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illness affect care-seeking strategies? How do 
care-seeking strategies interact with conditions 
of social, emotional, and financial duress? The 
many nuanced interconnections among these 
questions require a methodology that gives 
patients and family members a forum to artic-
ulate their experiences in their own terms. Con-
sequently, most social scientists build in-depth 
case histories through long-term research in 
local settings. Many conduct multiple interviews 
over an extended period to track shifts in how 
patients and family members interpret and strat-
egize around the disease. Often, these studies 
reveal disjunctures and disconnections between 
patient understanding of disease and those of 
medical specialists. Invariably, these enrich the 
epidemiologic picture or challenge it.
For example, in 1994, Hunt1,2 conducted 
interviews with patients and family members 
in southern Mexico and asked, “Why do you 
think this person got sick?” In the answers she 
received from patients and caregivers, she noted 
a strong moral tone, including all manner of 
flawed behavior—adultery, hedonism, domes-
tic violence, promiscuity—that invokes images 
of purity and danger, propriety and misconduct, 
and goodness and evil. Consequently, patients 
and family members may understand the heal-
ing process as dependent on identifying and 
eliminating moral ills in addition to chemother-
apy, radiotherapy, and other medical interven-
tions. The physicians in Hunt’s sample, on the 
other hand, approached cancer as solely a med-
ical and technical problem. Hunt suggested a 
bridging of these perspectives to enhance thera-
peutic effectiveness. Such insights are critical for 
policies around access, with genuine uptake by 
local communities.
A number of other studies have explored similar 
questions. In an ethnographic study of a Chi-
nese village, Lora-Wainwright3 examined cancer 
etiologies and their implications for therapeu-
tic inaction. Mulemi4-8 conducted research in 
a cancer ward in Kenya to study how patients 
experience and make sense of biomedical treat-
ments. Through her work in a hospital in Mum-
bai, India, Macdonald9,10 focused on visions of 
hope among breast cancer volunteers. Broom et 
al11-14 examined medical pluralism, experiences 
of stigma, and shared decision making among 
patients with cancer in Hyderabad, India. These 
studies go beyond a reductionist psychological 
model of individual behavior by providing us with 
a more realistic account of the complex relations 
between interpretations of illness and care-seeking 
strategies.
PRACTICES AMONG ONCOLOGISTS AND NURSES
Although the understanding of patients’ socially 
and culturally inflected interpretations of illness 
falls within the expertise of anthropologists, sociol-
ogists, and historians, one might not expect 
social scientists to comment extensively on the 
practices of oncologists and nurses. What could 
a social scientist possibly know about medicine 
that medical practitioners do not themselves 
already know? Although oncologists and nurses 
frequently are aware of the distinct social, polit-
ical, and economic forces that shape medical 
institutions and medical interventions, they do 
not always have the time to study these forces 
systematically amid the daily pressure to deliver 
care to a large number of patients.
Recent work has explored regimes of onco-
logic practice in low- and middle-income coun-
tries. Among the most prominent publications is 
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Table 1. Key Contributions of Social Science to Cancer Care in Low- and Middle-Income Countries
Social Studies Can Provide Perspectives on the Cancer Burden in Low- and Middle-Income Countries to Inform Policy That:
Extends the range of relevant policy agendas beyond a focus on behavior and compliance to the more nuanced, context-specific policy 
challenges only discernible through long-term empirical research
Examines actors and institutions at the local, national, regional, and international levels and the positive and negative effects of their arrangement 
in a wider health system
Relies on critical social theory instead of a reductionist psychological model of individual behavior that often blames people for their illness
Demonstrates how cultural logics; local, regional, and global histories; and political, economic, and environmental circumstances shape popular 
and biomedical perceptions and knowledge of cancer, causation, treatment, and prevention
Deploys a frame of analysis that captures the lived experience of patients, family members, oncologists, and nurses to avoid the production of 
decontextualized survey data
Takes research and policy itself as an object of analysis, thereby generating insights into how research and policy agendas often are driven by 
concerns and priorities of high-income countries
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Livingston’s book Improvising Medicine,15 which 
looks at the ways in which oncology practice in 
Botswana specifically and Africa generally dif-
fers from the practice of oncology in the United 
States and Europe. In the absence of state-
of-the-art therapeutic and diagnostic equip-
ment, Livingston shows how the oncologist in a 
Botswana oncology ward resorts to alternative 
modes of establishing a diagnosis and admin-
istering treatment. Oncologists in these settings 
must review both new and old medical journals 
to piece together treatment protocols with out-
dated technologies. An ever-growing number of 
patients puts an already overloaded infrastruc-
ture under pressure, which makes it difficult for 
physicians to provide patients with adequate 
care. Livingston asked, “What is the best way for 
an oncologist to proceed in such a setting?" She 
found that improvisation is not an exception, but 
a norm.16 Along with Livingston, several social 
scientists have shown that cancer is shaped as 
much by social, political, and economic condi-
tions and shifting health care practices as it is 
by aberrant cellular mechanisms.17 Without an 
understanding of the experiences of oncologists 
and nurses in resource-poor settings, education 
and training initiatives can easily fall wide off the 
mark.
INTERDISCIPLINARY COLLABORATIONS
Interdisciplinary collaborations between social 
scientists and oncologists have delivered import-
ant insights for global cancer control and provide 
a template for future work. We dissect out these 
types of studies along thematic and country 
lines.
Treatment Access and Administration
Cancer has long been considered a disease of 
mainly high-income countries.18 However, his-
torical research shows that cancer always has 
been a health issue in low- and middle-income 
countries. The current concern with cancer as a 
major cause of death and disability in low- and 
middle-income countries needs to be situated 
within longer histories of cancer and cancer 
care. Often forgotten is that hospitals, such as 
Tata Memorial in Mumbai, and other medical 
institutions in low- and middle-income countries 
have been providing specialized treatments for 
decades to patients with cancer, not only in their 
own populations but globally, as well, through 
international networks. Yet even in well-devel-
oped oncology centers, major challenges to 
accessing and administering treatment remain. 
We focus on treatment challenges in Uganda, 
Rwanda, Iraq, and India.
Uganda. Since 2010, Mika19 has conducted 
research at one of the oldest sites that pro-
vides medical oncology services in sub-Saharan 
Africa, the Uganda Cancer Institute (UCI), which 
opened its doors in the late 1960s to treat 
Burkitt’s lymphoma and a range of solid tumors. 
Mika’s findings can be summed up in one sen-
tence: Ugandan physicians, nurses, laboratory 
technicians, and palliative care specialists all 
exhibit tremendous creativity in times of a grow-
ing cancer crisis.
Mika began her work at UCI at a moment when 
senior leadership was particularly interested in 
excavating the rich history of the site. The col-
laborations with UCI have focused on archival 
preservation and have drawn on the history of 
cancer research and care to shape policy in the 
present. The collaboration also has created a 
space to reflect on the ethics of long-term eth-
nographic research in a hospital setting and how 
history can inform policy. UCI houses records 
on patients that date back to the mid-1960s. If 
preserved and made accessible, these would be 
an invaluable collection on the epidemiology and 
treatment of cancer on the African continent. By 
working with senior staff at UCI, Mika hopes to 
restore, digitize, and create an accessible data-
base of these records in the next 2 to 3 years.
Rwanda. Djordjevic’s20 research looks at national 
oncology in Rwanda, where she has been con-
ducting research since 2010. During 2010, she 
witnessed the gradual beginnings of oncology in 
the form of a breast and cervical cancer preven-
tion campaign launched by the Ministry of Health 
in collaboration with Partners In Health, a Bos-
ton-based nongovernmental organization (NGO) 
already substantially engaged with the public 
health sector infrastructure and care delivery. In 
2012, these partners and others inaugurated the 
Butaro Cancer Center of Excellence, Rwanda’s 
first public cancer center, nestled in the hills 
of northern Rwanda near the border with Uganda. 
From the beginning, the center has been the 
product of significant transnational private-public 
partnerships. Treatment is delivered by young 
Rwandan physicians and American clinicians 
(most fresh out of residency) affiliated with 
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Harvard University hospitals. Chemotherapy is 
paid for by Partners in Health, and on a monthly 
basis, the organization selects 7 to 12 patients 
who they send to the Nairobi Hospital in Kenya 
for radiation therapy.
What are the major insights to be gleaned from 
Rwanda’s public oncology program? One is that 
we need to pay close attention to how private 
and public are defined on the ground given the 
widespread prevalence of private-public part-
nerships for oncology in low- and middle-income 
countries. What remains compelling and unique 
is that despite major private contributions from 
abroad and heavy financial dependence on such 
contributions, Rwanda produces and exercises 
national ownership over the oncology program in 
a variety of ways. In certain respects, the pro-
gram is a model for oncology in low- and middle- 
income settings, but a critical eye helps us to 
understand the limitations and strengths of vari-
ous aspects of the model and how to apply these 
in Rwanda and beyond. Another is that oncology 
holds particular power for the Rwandan national 
imaginary given the technologically demanding 
treatments and modalities that cancer requires. 
Such understanding is important for the political 
dimension of cancer control and informs how 
externally supported developments of cancer 
care should be nuanced to suit local realpolitik.21
Iraq. Skelton et al’22,23 research looks at cancer 
care in the context of war and mobility in Iraq, 
particularly in the northern provinces. They track 
the mobility and strategies of Iraqis with late-
stage cancer as they move across provincial and 
international borders in pursuit of oncology care. 
This research explores how cancer is increas-
ingly a disease that, particularly in the conflict 
settings of the Middle East, is managed across 
both domestic and international borders. Iraq’s 
once robust oncology infrastructure has faced 
25 years of de-development as a result of United 
Nations sanctions (1991 to 2003) and insecurity 
(2003 to present). This process has generated 
new strategies of care seeking and an emerg-
ing regional geography of care. Patients man-
age war-induced deficiencies in care by piecing 
together treatments across multiple domestic 
provinces and international sites. This interpro-
vincial sojourning is largely a function of the fact 
that Iraqi public hospitals negotiate the problem 
of pharmaceutical shortages and the mandate to 
provide universal care by rationing limited doses 
per patient, which means that one is forced to 
complement these provisions either through 
movement between provinces or internationally. 
And yet, this movement itself is complicated or 
inhibited by security/checkpoint policies and 
threats of violence.
In addition to conducting his own research, 
Skelton has co-led two collaborative projects 
with oncologists, one based in Lebanon and the 
other based in Iraq. In Lebanon, he has collab-
orated with a team of oncologists based at the 
American University of Beirut Medical Center in 
a mixed-methods qualitative/quantitative study 
on the financial hardships of Iraqi patients with 
cancer who undergo treatment in Lebanon. In 
Iraq, Skelton is collaborating with oncologists 
based at three public cancer centers to inves-
tigate the pathways of cancer care for displaced 
patients.24 This research looks at the networks 
and pragmatics that enable families and patients 
to access the out-of-pocket resources needed 
to manage the enormous financial burdens of 
cancer care amid conflict conditions that already 
deplete incomes and destroy livelihoods (Skelton 
et al, manuscript submitted for publication).
India. Sivaramakrishnan’s work, which is based 
on research in the northern state of Punjab, 
traces the mobility and migration that patients 
and health practitioners have struggled with 
both past and present because care is clus-
tered in urban metropolises that require travel 
and resources. Sivaramakrishnan also explores 
the fractured networks of mobility involved in 
consulting for care and reconciles diverse thera-
peutic strategies among plural systems of medi-
cine from homeopathic pharmacies to Ayurvedic 
clinics to rural medical practitioners. Currently in 
India, cancer campaigns have been revised and 
recast since the formulation of state and national 
policies, but still, class and epidemiologic hier-
archies are frequently conflated, and specific 
cancers are still associated with certain popula-
tions (eg, cervical, oral). Differentiation of these 
cancers from the more upper-class cancers of 
the breast persist. Sivaramakrishnan stresses 
that some of the biggest challenges to deepen-
ing cancer-related research and affordable care 
in low- and middle-income countries remains a 
reluctance among politicians, philanthropists, 
and the middle-class public to view cancer as an 
urgent and universal public health priority.
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Prevention and Screening
On the basis of fieldwork in Tamil Nadu, India, 
anthropologist Van Hollen25 (manuscripts sub-
mitted for publication) has explored perceptions 
of cancer causality, prevention, and treatment 
in response to government and NGO advocacy 
efforts to promote screening for reproductive 
cancers (particularly cervical and breast cancer) 
in low-income communities. Like many other 
countries, India faces a major problem in terms 
of early detection and treatment of cancer. Most 
people do not seek medical care for cancer until 
the disease has progressed to advanced stages. 
Until recently, screening interventions have 
been scarce and too costly (in terms of both time 
and money) for poorer populations. Fear and 
social stigma associated with cancer also have 
deterred early detection. In response to these 
societal conditions, global, national, state, and 
NGO institutions are actively engaged in devel-
oping programs to increase screening and early 
detection.
By contesting the notion that global public inter-
ventions disregard local sociocultural contexts,26 
Van Hollen’s research has shown that public 
health planners take great pains to localize the 
educational messages to increase the use of 
screening and early detection. Too often, how-
ever, such culturally appropriate public health 
messages convey highly moralizing judgments. 
They imply behavior norms associated with sex-
ual and reproductive practices, age of marriage, 
food, exercise habits, and tobacco use. By using 
social science methods that combine observa-
tion with qualitative, open-ended interviews with 
physicians, nurses, public health counselors, 
and people with low incomes who are the tar-
gets of these campaigns, Van Hollen has been 
exploring how these culturally appropriate mes-
sages may further stigmatize cancer and deter 
screening.
Social science research on cancer screening 
and prevention interventions around the world 
can help to avoid the pitfalls of moralizing dis-
courses. Such studies are critical if global cancer 
prevention measures are to gain national political 
traction. These studies bring the voices of com-
munities targeted by public health programs to 
the table. A shift away from individual causality 
can foster a more robust and politically challeng-
ing debate about the need for more regulation 
of the global production and consumption of 
potentially carcinogenic substances, which will 
add to the traditional econometric approaches.27
As Mueller’s historical research has shown, tox-
icologic studies often are based on factory and 
other workplace settings common in early 20th 
century Europe and North America. These stud-
ies often have been limited to animal experiments 
in highly controlled laboratory environments. 
Such studies may not capture the more com-
plex relations of exposure in agricultural labor, 
including exposure pathways that are shaped by 
interactions of various chemicals, sunlight, rain, 
and other environmental conditions.28 Historical 
accounts have suggested that studies on spe-
cific exposures in low- and middle-income coun-
tries are urgently needed, especially because 
pesticides, naturally occurring carcinogens, and 
other toxic substances may behave differently in 
other environmental conditions and that such 
studies should take community concerns seri-
ously because these might point toward previ-
ously unrecognized toxic exposures.
This approach would require better funding for 
occupational health programs and testing lab-
oratories. Agricultural development programs, 
sponsored by international donors, will need to 
take toxic exposure and cancer prevention into 
consideration when designing interventions. 
Social science research can help with under-
standing assumptions in toxicologic knowledge 
and the limits of implementation of legal regula-
tions. With that, the social sciences can help to 
broaden cancer prevention from being limited to 
immediate biomedical interventions to address-
ing the problem of toxic exposure to carcino-
genic substances more generally.
Palliative Care
Banerjee’s research on terminal cancer care in 
India highlights the need to strengthen pallia-
tive care infrastructures. Although cancer inci-
dences are higher in high-income countries, the 
burden of mortality falls disproportionately on 
low- and middle-income countries. To under-
stand the social lives of those who seek palliative 
care in Delhi, India, Banerjee conducted 1 year 
of ethnographic interviews and observations with 
cancer care NGOs and hospitals as well as in 
the homes of low-income patients with cancer 
and their families. His research has revealed 
and answered an important ethical conundrum 
that faces global cancer care: How might public 
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health practitioners aid urban poor patients in 
their time of dying without losing sight of the 
need to expand access to treatment and path-
ways to survival?
The past two decades have witnessed the devel-
opment of at least two contrasting models. In 
Delhi, the NGO CanSupport has pioneered the 
delivery of expert care by teams of professionals 
to the homes of urban poor patients. In Kerala, 
a state with a long history of communist mobili-
zations, groups such as Pallium India and the 
Neighborhood Network in Palliative Care have 
advocated a community-based approach by 
training large groups of volunteers to deliver care 
to their neighbors and kin. These palliative care 
efforts have revealed three things. First, although 
low- and middle-income countries lag in can-
cer care, they have been sites of innovation 
with lessons for high-income countries, espe-
cially resource-rich countries like the United 
States that have mobilized around tertiary care 
and expensive cancer technologies rather than 
around accessible end-of-life care. Second, the 
development of cancer care in low- and mid-
dle-income settings confronts difficult choices 
between access and expertise. A crucial task for 
palliative care work (and indeed for cancer care 
in general) is to understand existing networks of 
care and to adapt and articulate with them organ-
ically, which involves an understanding of social 
worlds of support as both sources of stigma, 
violence, abuse, and neglect and sources of 
potential help and support. To this end, Baner-
jee collaborated with palliative care physicians in 
northern India’s largest public health facility: the 
All India Institute for Medical Science. Together, 
they published a clinical audit of the palliative 
care unit’s pain assessment procedures. This 
collaborative work across the social and biomed-
ical sciences emphasized the need to pay closer 
attention to psychosocial etiologies of distress in 
clinical practice.29 Third, palliative care organi-
zations in low- and middle-income countries 
share a fundamental concern: the availability 
of effective analgesia. Oral morphine and other 
opiate-based painkillers are fundamental to the 
effective treatment of cancer pain, yet < 3% 
of patients with cancer in India have access to 
oral morphine. Of note, this problem is not one 
of scarcity. Although India produces > 90% of 
the world’s licit opium, opiates rarely have been 
available within the country because of strict 
drug legislation. The efforts of palliative care 
professionals has led to the relaxation of rules in 
some Indian states, but physicians from higher- 
class backgrounds continue to fear addiction 
among lower-class patients and rarely prescribe 
the drug. Here we see again that framing the 
problem of cancer in low- and middle-income 
countries in terms of scarcity elides the complex 
social, cultural, and political factors that promote 
and/or inhibit cancer care.
DISCUSSION
Social scientists are committed to studies that 
foreground the narratives of a wide range of 
stakeholders (ie, patients, family members, medical 
practitioners at all levels and from many systems 
of medicine, researchers, policymakers) to give 
voice to the lived experiences, motivations, and 
constraints of all who are touched by cancer and 
involved in cancer care. This approach human-
izes and adds richness to our understanding 
of cancer in heterogeneous and complex set-
tings across low- and middle-income countries. 
Social science research favors studies that span 
extended periods for continuous observation and 
engagement. It enables interdisciplinary collabo-
rations and generates unique analyses that other 
methods cannot offer and that clinicians often 
cannot conduct given the pressing demands of 
delivering medical care. A significant benefit is 
that social scientists usually return to the same 
research site. The personal connections and 
experiences that grow over time enable social 
scientists to have a thorough understanding of 
changing conditions that affect oncology.
Social science research not only reveals the mis-
eries and stigma of patients, the lack of access to 
medical care, and the fraught social negotiations 
of the sick and their families but also interro-
gates the quality and efficacy of the interventions 
extended and delivered to low- and middle-income 
countries. Cancer treatment demonstration pro-
grams often increase inequities within poor 
countries by establishing state-of-the-art cancer 
clinics that serve only a fraction of the popula-
tion. The goal of social science research is not 
to undermine the global oncology equity agenda 
but to retain a deep analysis of risk-benefit equa-
tions, resource-intensive technologies, patient 
experience, and sustainability, which are crucial 
for well-informed policy.
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A key question for policymakers is how to 
respond to the uneven ways in which medical 
institutions are evolving in a world that is increas-
ingly marked by the privatization of health care. 
In places with no or little health insurance cover-
age, the responsibility of shouldering health care 
costs often is left to patients and family members 
as out-of-pocket and catastrophic expenditures. 
The global cancer community is increasingly 
aware of the financial burden of treatments and 
the associated risk of exacerbating already-existing 
inequalities. To deliver accessible and affordable 
care for the benefit of patients, the global cancer 
community needs to move beyond the assump-
tion that low- and middle-income countries must 
catch up with or mimic the oncology principles 
of high-income countries.
Social science research reveals assertions and 
assumptions about cancer and its causes and 
consequences through medical anthropology, 
medical sociology, history of medicine, and 
related fields in low- and middle-income coun-
tries. Interdisciplinary collaborations can then 
extend across the social and medical sciences 
and high-, low-, and middle-income settings 
to understand the limitations that these asser-
tions and assumptions impose. Open discussion 
will help with developing more-effective and 
-comprehensive cancer policies that combine 
treatment, prevention, and palliative care for 
all. An urgent need exists for practice-informed 
social science research in countries where social, 
political, and economic inequalities are major 
determinants of poor cancer outcomes.30,31 National 
and international development priorities often do 
not fit well with the social, political, and economic 
conditions in low- and middle-income countries. 
National cancer control programs must be based 
on a robust understanding of local realities and 
lived experiences, which only social science can 
provide.
One of the reasons that social science approaches 
to the study of cancer have been historically 
under-represented in the cancer research litera-
ture is that the conclusions often emphasize local 
conditions; question basic assumptions; and call 
for social, cultural, and economic changes that 
are politically challenging. This reason should 
not deter social scientists from pursuing such 
studies. In fact, it should inspire us to redou-
ble our efforts and find ways to convey findings 
clearly to a broader audience in the interests of 
improving cancer care around the globe.
DOI: https://doi.org/10.1200/JGO.18.00045 
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